We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking AYTU? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AY

Aytu BioPharma, Inc. (AYTU) short interest & options flow

NASDAQ

Aytu BioPharma reported Q3 2026 results after the close on May 13, landing into an already-weakened stock — and the headline numbers tell a split story worth watching closely. The print itself was mixed. EPS came in at -$0.53, missing the -$0.51 consensus. Revenue of $12.4 million beat estimates of $12.1 million but continued to trend lower — down year-on-year, extending a pattern…

$1.81+1.12% 1d-6.22% 1w-10.62% 1mClose: 10 Nov 2026
Short interest % of float
Rising
Live SI on ORTEX →
Cost to borrow
High
Live CTB on ORTEX →
Availability
Dropping
Live availability on ORTEX →
Market cap
$20M
Next earnings
13 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 12 Nov 2026

ORTEX chart of Aytu BioPharma, Inc. (AYTU) share price and short interest (% of free float), six months to November 10, 2026

AYTU news and analysis

RSS

No long-form analysis yet for AYTU. Pulse alerts and the live data picture are available on ORTEX.

Open AYTU on ORTEX →

Want the live picture for AYTU?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AYTU — free to start on ORTEX.

Sign up for free →Open AYTU on ORTEX